Skip to Main Content

A long-awaited video game meant to be prescribed to kids with ADHD is finally being rolled out — though not in the way its maker, Akili Interactive Labs, had ever imagined.

On Wednesday, the Boston-based startup launched an enrollment website to make its game available for free for eligible children for up to three months during the pandemic period. The rollout comes in response to the Food and Drug Administration’s move last week to relax regulations on low-risk mental health devices. Akili’s game is still pending regulatory approval, and as such it won’t be prescribed by physicians or covered by insurers as part of the unusual launch.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED